Dermatologists' role in addressing rising vaccine hesitancy - 20/12/25
Doi : 10.1016/j.jaad.2025.10.158
Adarsh Shidhaye, BS a, ⁎ 
, Gabrielle Schwartzman, MD b, Barrett Zlotoff, MD b, Jane M. Grant-Kels, MD c, d
, Gabrielle Schwartzman, MD b, Barrett Zlotoff, MD b, Jane M. Grant-Kels, MD c, d a Department of Biomedical Sciences, University of South Carolina School of Medicine Greenville, Greenville, South Carolina
b Department of Dermatology, University of Virginia School of Medicine, Charlottesville, Virginia
c Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut
d Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida
∗Correspondence to: Adarsh Shidhaye, BS, Department of Biomedical Sciences, University of South Carolina School of Medicine Greenville, 607 Grove Rd, Greenville, SC 29605.Department of Biomedical SciencesUniversity of South Carolina School of Medicine Greenville607 Grove RdGreenvilleSC29605
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Saturday 20 December 2025
Key words : anogenital malignancies, biologics, communicable diseases, exanthems, genital warts, HPV vaccinations, human papillomavirus, immunosuppressed patients, influenza vaccine, measles, monkeypox, pneumococcal vaccine, prevention, rubella, school vaccine mandates, shingles vaccine, vaccine hesitancy, vaccines, WHO, World Health Organization
Plan
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
© 2025
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?